Advocating for a world where intellectual
property law serves the public interest.
Mark Dybul, Executive Director of the Global Fund has written an email responding to a letter from 220 civil society organizations demanding that the Global Fund abandon its “tiered-pricing” proposal. His response: “Thank you for your letter. Dialogue is healthy and we appreciate the opportunity to engage. Of course there has not been time to […]
Key data on prices, regulatory status, tariffs and the intellectual property situation [World Health Organization] OVERVIEW: The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral treatments recommended by WHO. It links this information with an analysis of the intellectual property situation of the selected medicines […]
A recent judgment from the Court of Justice of the European Union (Case C-435/12 ACI Adam BV and Others) ruled that private copying limitations cannot permit downloads from unlawful sources. João Pedro Quintais & Alexander de Leeuw, have a detailed peice on the case on the Kluwer Copyright Blog. Here is an excerpt from the […]
Below is a communication sent by Civil Society Organizations to Mark Dybul and others calling for the abandonment of the Global Fund’s misguided tiered-pricing initiative. The CS letter is attached. Dear Dr. Dybul, Dr. Chan, and Executive Directors of Proposed Convening Partners (UNITAID, UNICEF, World Bank, UNDP and GAVI): Attached is a letter from 220 […]
Eli Lilly’s challenge of Canadian judicial decisions under NAFTA’s Investor-State Dispute Settlement (ISDS) is leading to concerns about ISDS in other trade negotiations. The company alleges that Canada violated its NAFTA obligation to grant patents on any inventions that “are new, result from an inventive step and are capable of industrial application” when courts found […]
[Medicines Patent Pool press release, Link, (CC-BY)]The report provides an overview of the patent and licensing status of a select number of antiretroviral medicines in developing countries. Focusing mainly on ARVs recommended by the World Health Organization, the document analyses also data regarding new ARVs that have either recently obtained regulatory approval or are in […]
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources